Edesa Biotech, Inc. (EDSA:NASDAQ) closed at $2.77 on October 23, 2026, up 0.36% on the day. The stock trades 86.4% below its 52-week high of $20.32 and 284.7% above its 52-week low of $0.720. Over the past year, it gained 1.1%. Edesa Biotech, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, EDSA closed higher on 100 days (40%). Its best day was March 3, 2026 (+90.79%) and its worst was May 18, 2026 (-31.03%). The stock moved 10% or more in a single session 37 times. It opened at least 5% above the previous day's high 3 times.
Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.
Find more stocks like EDSA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.